Why It Might Not Make Sense To Buy Associated Banc-Corp (NYSE:ASB) For Its Upcoming Dividend
The company's next dividend payment will be US$0.23 per share, on the back of last year when the company paid a total of US$0.92 to shareholders. Based on the last year's worth of payments, Associated Banc-Corp stock has a trailing yield of around 4.0% on the current share price of US$23.12. If you buy this business for its dividend, you should have an idea of whether Associated Banc-Corp's dividend is reliable and sustainable. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. Associated Banc-Corp paid out 107% of its earnings, which is more than we're comfortable with, unless there are mitigating circumstances.
When a company pays out a dividend that is not well covered by profits, the dividend is generally seen as more vulnerable to being cut.
Check out our latest analysis for Associated Banc-Corp
Click here to see the company's payout ratio, plus analyst estimates of its future dividends.
When earnings decline, dividend companies become much harder to analyse and own safely. Investors love dividends, so if earnings fall and the dividend is reduced, expect a stock to be sold off heavily at the same time. Readers will understand then, why we're concerned to see Associated Banc-Corp's earnings per share have dropped 16% a year over the past five years. Such a sharp decline casts doubt on the future sustainability of the dividend.
We'd also point out that Associated Banc-Corp issued a meaningful number of new shares in the past year. It's hard to grow dividends per share when a company keeps creating new shares.
Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. Associated Banc-Corp has delivered an average of 9.8% per year annual increase in its dividend, based on the past 10 years of dividend payments. The only way to pay higher dividends when earnings are shrinking is either to pay out a larger percentage of profits, spend cash from the balance sheet, or borrow the money. Associated Banc-Corp is already paying out a high percentage of its income, so without earnings growth, we're doubtful of whether this dividend will grow much in the future.
Has Associated Banc-Corp got what it takes to maintain its dividend payments? Earnings per share are in decline and Associated Banc-Corp is paying out what we feel is an uncomfortably high percentage of its profit as dividends. Generally we think dividend investors should avoid businesses in this situation, as high payout ratios and declining earnings can lead to the dividend being cut. This is not an overtly appealing combination of characteristics, and we're just not that interested in this company's dividend.
Having said that, if you're looking at this stock without much concern for the dividend, you should still be familiar of the risks involved with Associated Banc-Corp. In terms of investment risks, we've identified 1 warning sign with Associated Banc-Corp and understanding them should be part of your investment process.
Generally, we wouldn't recommend just buying the first dividend stock you see. Here's a curated list of interesting stocks that are strong dividend payers.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Matador Restaurant Group files for bankruptcy
Matador Restaurant Group, a Del Taco franchisee operating 22 outlets, has declared bankruptcy amidst financial struggles. The South Carolina, US-based company reported assets and liabilities each between $1m and $10m, alongside more than $2.7m in merchant cash advance (MCA) debts. Matador's owner, Red Door Brands, manages other food chains including Little Caesars and Arby's. But they have not faced similar financial issues and will undergo separate bankruptcy proceedings, as reported in RestaurantBusinessOnline. Each filing pointed to the Del Taco operations and the MCA financing as the root of their problems. Court documents reveal that the Del Taco restaurants began struggling in late 2024 due to 'company growth, an unexpected decline in sales and rising operational costs.' The company resorted to MCA financing as a temporary solution to address cash flow problems, based on the advice of its brokers. MCA providers in the case of Matador have recently intensified collection efforts, with several creditors asserting their interests through UCC-1 [Uniform Commercial Code] financing statements and one placing a lien on the company's accounts. This action has complicated the brand's operations, prompting the bankruptcy filing to halt collections and facilitate reorganisation. In February 2025, Del Taco signed an agreement to open ten outlets in Indiana. The following month, Del Taco abruptly closed almost all its restaurants in Colorado, US, without unveiling details of its decision. These closures, undertaken by franchisee Newport Ventures, are reportedly due to bankruptcy proceedings involving the franchisee. In June 2025, the chain announced plans for a significant expansion into the Louisville, Kentucky area through a five-store development deal with new franchisee and local restaurant operator Karan Pandher, marking the chain's first entry into the Louisville market. "Matador Restaurant Group files for bankruptcy" was originally created and published by Verdict Food Service, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
2 minutes ago
- Yahoo
US business inventories unchanged in May
WASHINGTON (Reuters) -U.S. business inventories were unchanged for a second straight month in May, suggesting that inventories could subtract from gross domestic product in the second quarter. The flat reading in inventories reported by the Commerce Department's Census Bureau on Thursday was in line with economists' expectations. Inventories are a key component of GDP. They increased 1.7% year on year. Inventories are also the most volatile component of GDP. They surged at a $160.5 billion annualized rate in the first quarter as businesses stocked up ahead of President Donald Trump's sweeping tariffs on imported goods, adding 2.59 percentage points to GDP, the most since the fourth quarter of 2021. But that was insufficient to offset a record 4.61-percentage-point drag from a sharp widening in the trade deficit that resulted from the imports deluge. The economy contracted at a 0.5% pace in the January-March quarter. Retail inventories gained 0.3% in May as estimated in an advance report published last month. They were unchanged in April. Motor vehicle inventories increased 0.6% as previously reported. They fell 0.7% in April. Retail inventories excluding autos, which go into the calculation of GDP, rose 0.2% as initially reported. Wholesale inventories fell 0.3% in May, while stocks at manufacturers rose 0.1%. Business sales dropped 0.4% in May after declining 0.2% in April. At May's sales pace, it would take 1.39 months for businesses to clear shelves, up from 1.38 months in April. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 minutes ago
- Yahoo
Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors
Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but the stock still plummeted nearly 10% after management dialed back earnings and growth projections for the rest of the year. The company reported second-quarter sales of $11.14 billion, beating the consensus of $11.07 billion. Second-quarter sales increased 7.4% on a reported basis, 6.9% on an organic basis, or 7.5% when excluding COVID-19 testing-related U.S. MedTech giant reported adjusted earnings of $1.26, beating the consensus of $1.25, and within the management guidance of $1.23-$1.27. 'Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly expanded our margin profiles, and continued to advance key programs through our new product pipeline,' said Robert B. Ford, chairman and chief executive officer, Abbott. 'We see this momentum carrying into 2026.' Medical Devices sales increased 13.4% on a reported basis and 12.2% on an organic basis to $5.37 billion. Sales growth in the quarter was led by double-digit growth in Diabetes Care, Heart Failure, Structural Heart, and Electrophysiology. Several products contributed to the performance, including FreeStyle Libre, Navitor, TriClip, and AVEIR. In Diabetes Care, sales of continuous glucose monitors were $1.9 billion and grew 21.4% on a reported basis and 19.6% organically. Worldwide Nutrition sales increased 2.9% (+3.4% on an organic basis) to $2.21 billion. View more earnings on ABT Growth in the quarter was led by Adult Nutrition, where global sales increased 6.1% (+6.6% on an organic basis), led by strong growth of Ensure and Glucerna. Global Diagnostics sales decreased 1% (-1.4% on an organic basis) and increased 0.8% when excluding COVID-19 testing-related sales. The year-over-year decline in COVID-19 testing-related sales and volume-based procurement programs in China impacted diagnostics sales growth. COVID-19 testing-related sales were $55 million in the quarter, compared to $102 million a year ago. Established Pharmaceuticals sales increased 6.9% (+7.7% on an organic basis) to $1.38 billion. Abbott's reported operating margin of 18.4%, with an adjusted operating margin of 22.9%, which reflects a 100 basis point increase. Guidance Abbott narrowed full-year 2025 adjusted earnings guidance from $5.05-$5.25 per share to $5.10-$5.20 per share compared to the consensus of $5.16. The company expects organic sales growth of 7.5%-8.0% compared to prior guidance of 7.5%-8.5%, or 6.0% to 7.0% when including COVID-19 testing-related sales. Abbott forecasts an adjusted operating margin of approximately 23.5% of sales, down from prior guidance of 23.5%- 24.0%. Abbott expected third-quarter 2025 adjusted earnings of $1.28-$1.32 per share, compared to the consensus of $1.34 per share. During the earnings conference call, an Abbott executive addressed the impact of tariffs, reporting that the estimated headwind has been revised down to $200 million for the year, lower than previous estimates. Price Action: ABT stock is trading lower by 8.00% to $121.21 at last check Thursday. Read Next:Photo via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? ABBOTT LABORATORIES (ABT): Free Stock Analysis Report This article Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.